Insights On Outsourced Drug Development
-
Mechanical Engineering Design Process For Combination Products
7/17/2026
Mechanical engineering for combination drug-delivery devices demands more than good design — it requires data-driven risk management from specs through simulation. Learn how a structured phase approach ensures global manufacturing readiness.
-
Cost And Scalability Key Drivers Of Expanded Gene Therapy Access
5/16/2025
Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.
-
Accelerating Method Development And Manufacturing Of GLP-1 Analogs
7/29/2025
Explore a streamlined LC-UV/MS workflow that empowers labs to meet rising GLP-1 drug demand with faster, more informed decisions that enhance compliance and impurity detection efficiency.
-
Assessing Production And Stability Of Antibody Drug Conjugate Platforms
9/24/2025
ADCs with similar antibody sequences can behave differently due to linker and payload choices. Analytical tools reveal structural and stability differences critical to therapeutic performance.
-
Why Early Device Decisions Matter: How Immunovant Accelerated Its Program
10/15/2026
Deferring autoinjector selection can seem to preserve flexibility, yet it often moves constraints downstream. Integrating the device during Phase IIb changed one program's timeline and removed bridging work.
-
A Sensory Panel Study With The Focus On High-Intensity Sweeteners
8/5/2026
Gain insight into the sensory performance of five high-intensity sweeteners in a simulated bitter formulation, including their effects on sweetness, bitterness, aftertaste, and covering ability.
-
Overcoming Gene Therapy Cost Roadblocks On The Path To Patients
7/23/2025
Viral vector-based gene therapies are expanding beyond rare diseases to treat larger populations. Discover how innovations in manufacturing are making these life-changing treatments more accessible.
-
Development Of Scalable Purification For Biotherapeutic Peptides
8/26/2025
Discover key strategies for reversed-phase isolation of biotherapeutic peptides, as well as learn about method development, scale-up techniques, and RP/MS analysis to enhance purification workflows.
-
Oral Delivery Of PROTACs: Integrating Molecular Design And Enabling Formulation
8/20/2026
Explore how integrated molecular design and formulation strategies can overcome the unique oral-delivery challenges of PROTACs, transforming complex degraders into viable, scalable medicines.
-
Particles In High Concentration Biotherapeutics
8/7/2025
Examine advanced analytical solutions that detect, characterize, and mitigate particle formation in high-concentration biotherapeutics caused by protein aggregation and surfactant degradation.